Press Releases

SAN DIEGO, Jan. 2, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13th at 4:00 p.m. PST/

INDIANAPOLIS, Jan. 2, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020. David A. Ricks, Lilly's chairman and chief executive officer, will participate in a fireside chat at

SAN DIEGO, Jan. 2, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Matthew K. Harbaugh as executive vice president and chief financial officer (CFO) effect

ORLANDO, Fla., Jan. 2, 2020 /PRNewswire/ -- Mindfulness has become mainstream in the past decade gracing the covers of magazines and making waves in wellness circles and beyond while transforming the lives of celebrities and business leaders alike. As we ring in the next decade,

BALTIMORE and WASHINGTON, Jan. 2, 2020 /PRNewswire/ -- Lutheran World Relief and

SILVER SPRING, Md., Jan. 2, 2020 /PRNewswire/ -- Amid the epidemic levels of youth use of e-cigarettes and the popularity of certain products among children, the U.S. Food and Drug Administration today

SANTA CRUZ, Calif. and SAN MATEO, Calif., Jan. 2, 2020 /PRNewswire/ -- Fullpower® Technologies, "The sleep technology company" and OPOS, "The opioid optimization company", are announcing a partnership to create "The first 24/7 opioid compliance solution".  The solution combines Fullpower's patented contactless biosensing p

NEW YORK, Jan. 2, 2020 /PRNewswire/ -- EmblemHealth, one of the nation's largest non-profit health insurers, announced that effective January 1, 2020, it has significantly reduced the number of medical procedures for which members will require prior authorization before receiving care. The change impacts all of EmblemHealth's health ins

WOONSOCKET, R.I., Jan. 2, 2020 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation's common stock. The dividend is payable on February 3, 2020, to holders

RADNOR, Pa., Jan. 2, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, and